Special Issue of BMB: Mathematics to Support Drug Discovery and Development

The Bulletin of Mathematical Biology (BMB, http://rd.springer.com/journal/11538), the official journal of the Society for Mathematical Biology, publishes research articles at the interface of biology and the mathematical sciences. With the encouragement of the editors (Alan Hastings and Reinhard Laubenbacher), we are soliciting original research articles for contribution to a special issue of BMB focusing on the mathematics being used in the biopharmaceutical (biopharma) industry. The goal of the issue is to help bridge the gap between academia and the biopharma industry working in similar areas, by communicating some of the types of mathematics used in biopharma. Article submissions are requested by June 30, 2017, with completion of reviews, acceptances/rejections, and any needed revisions by December 31, 2017.

We hope this issue will: help academics in math biology ground their research in problems with real need; highlight biopharma as an exciting career for mathematicians who want to see direct impact of their work on patients; and help foster industrial and academic collaborations in this field. Preference will be given to submissions that identify, either directly or as a future challenge, areas for academic and industrial collaboration. We encourage you to provide sufficient context to your submission as to how the research presented improves the discovery or development of new therapies, and the open challenges related to the research that academic groups could be better suited to undertake. We are especially interested in having original methodological articles.

Please let us know by Wednesday, March 15, 2017 if you are interested in submitting a research article for consideration in this BMB special issue, and what topic it would be on. Feel free to email us with questions before then. We hope you will be able to participate.

Best regards,
Richard Allen and Helen Moore
BMB Special Issue Guest Editors
Richard.Allen@pfizer.com and Helen.Moore@bms.com